Fighting Cancer with AI
summary
AI analyzes peripheral blood smears cell‑by‑cell with a trial comparing nearly 3 million human‑labeled cells vs 14 million AI images and achieves 94.5% concordance with experts. Automated metaphase karyotyping runs in 12 seconds vs 41 seconds for manual work and matches senior technician quality. New sequencers process ~30 genomes per run in 48 hours at under $1,000 each and an AI classifies a specific AML at 96.6% using genome data alone. GPT models are used to check drug interactions and answer patient queries.
AI-written summary · about
chapters (8)
- 0:00Introduction to clinical AI
- 1:28AI in diagnosis and imaging
- 4:52Genomic data and automation
- 6:49LLMs in medical practice
- 9:47Future of medicine outlook
- 11:54The evolution of cancer care
- 14:17Adopting AI in clinical labs
- 18:02From treatment to prevention
related talks
18mCan AI make us smarter than cancer
10mGenesis Final Round - Drylab AI
37mAI in medicine: where do we stand?
23mAI in the Life Science Sector
13mWhen AI Gets a White Coat
44mNext-Gen Therapies
29mCancer diagnostics enabled by machines: finding and classifying single tumor....
15mCan AI Finally Solve India’s Cancer Crisis?